Healing helminths: A systematic review of the anti-inflammatory and disease-modifying potential of helminth-derived proteins
- 1Pharmacology & Therapeutics, Galway Neuroscience Centre, Institute for Health Discovery and Innovation, and School of Pharmacy and Medical Sciences, University of Galway, Galway, Ireland
- 2Molecular Parasitology Laboratory, Institute for Health Discovery and Innovation, and School of Natural Sciences, University of Galway, Galway, Ireland
Abstract
Helminths secrete diverse immunoregulatory molecules that modulate host inflammatory responses, facilitating long-term persistence within the host. This capacity has prompted interest in helminth-derived molecules as potential therapeutics for diseases characterized by excessive or dysregulated inflammation. This systematic review with cross-study quantitative analysis synthesized evidence on helminth-derived immunomodulatory peptides, polypeptides, and proteins (HDIPs), focusing on their disease-modifying and anti-inflammatory effects in in vivo animal models of inflammatory disease. Following PRISMA 2020 guidelines, PubMed, Web of Science, and Medline were systematically searched for studies published up to February 2026. Sixty-five studies were included, encompassing >65 HDIPs derived from 20 helminth species. Most studies investigated mouse models of colitis, asthma, arthritis, and sepsis, with Fasciola hepatica and Acanthocheilonema viteae the most extensively studied helminth species. Across models, HDIPs consistently reduced disease severity, accompanied by decreased pro-inflammatory cytokine levels and increased anti-inflammatory cytokine levels. These findings demonstrate broad disease-modifying and anti-inflammatory activity across diverse HDIPs and experimental disease models. Collectively, the evidence supports HDIPs as promising candidates for the development of novel immunoregulatory therapies for inflammatory diseases.
Related
- Hunting for Helminths: short- and long-read shotgun metagenomics for helminth detection in faecal samples
- Potential adjunct disease-modifying effects of exercise and physical activity in multiple sclerosis: an umbrella review of disease activity/progression, safety, and inflammatory-neurobiomarker evidence
- A Systematic Audit of ClinicalTrials.gov: Helminth Baseline Data Collection in Checkpoint Inhibitor Trials in Parasite-Endemic Regions
- The Therapeutic Potential of Berry-Derived and Berry-Based Interventions in Inflammatory Bowel Disease: A Comprehensive Systematic Review of Preclinical and Clinical Evidence
- Antioxidant Activity and Anti-Inflammatory Potential of Rhododendron dauricum Flowers via UPLC-Q-TOF-MS/MS Combined with Network Pharmacology and In Vitro Validation
BibTeX
@article{stucke2026healing,
title = {{Healing helminths: A systematic review of the anti-inflammatory and disease-modifying potential of helminth-derived proteins}},
author = {Sienna Stucke and Aonghus Feeney and Richard Lalor and Sheila Donnelly and John Pius Dalton and Declan McKernan and Eilís Dowd},
journal = {Molecular Therapy},
year = {2026},
month = aug,
doi = {10.1016/j.ymthe.2026.08.038},
url = {https://doi.org/10.1016/j.ymthe.2026.08.038},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Healing helminths: A systematic review of the anti-inflammatory and disease-modifying potential of helminth-derived proteins
AU - Sienna Stucke
AU - Aonghus Feeney
AU - Richard Lalor
AU - Sheila Donnelly
AU - John Pius Dalton
AU - Declan McKernan
AU - Eilís Dowd
PY - 2026
DA - 2026/08/25
JO - Molecular Therapy
DO - 10.1016/j.ymthe.2026.08.038
UR - https://doi.org/10.1016/j.ymthe.2026.08.038
AB - Helminths secrete diverse immunoregulatory molecules that modulate host inflammatory responses, facilitating long-term persistence within the host. This capacity has prompted interest in helminth-derived molecules as potential therapeutics for diseases characterized by excessive or dysregulated inflammation. This systematic review with cross-study quantitative analysis synthesized evidence on helminth-derived immunomodulatory peptides, polypeptides, and proteins (HDIPs), focusing on their disease-modifying and anti-inflammatory effects in in vivo animal models of inflammatory disease. Following PRISMA 2020 guidelines, PubMed, Web of Science, and Medline were systematically searched for studies published up to February 2026. Sixty-five studies were included, encompassing >65 HDIPs derived from 20 helminth species. Most studies investigated mouse models of colitis, asthma, arthritis, and sepsis, with Fasciola hepatica and Acanthocheilonema viteae the most extensively studied helminth species. Across models, HDIPs consistently reduced disease severity, accompanied by decreased pro-inflammatory cytokine levels and increased anti-inflammatory cytokine levels. These findings demonstrate broad disease-modifying and anti-inflammatory activity across diverse HDIPs and experimental disease models. Collectively, the evidence supports HDIPs as promising candidates for the development of novel immunoregulatory therapies for inflammatory diseases.
SN - 1525-0016
SN - 1525-0024
ER -